`571.272.7822
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` Paper No. 89
`
` Filed: November 15, 2019
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`MYLAN PHARMACEUTICALS INC.,
`SAWAI USA, INC., AND
`SAWAI PHARMACEUTICAL CO., LTD.,
`Petitioner,
`
`v.
`
`BIOGEN MA INC.,
`Patent Owner.
`____________
`
`IPR2019-007891
`Patent 8,399,514 B2
`____________
`
`
`
`Before ANDREI IANCU, Under Secretary of Commerce for Intellectual Property
`and Director of the United States Patent and Trademark Office,
`ANDREW HIRSHFELD, Commissioner for Patents, and SCOTT R. BOALICK,
`Chief Administrative Patent Judge.
`
`
`
`PER CURIAM.
`
`
`
`
`ORDER
`
`
`1 IPR2019-00789 is joined to IPR2018-01403.
`
`
`
`IPR2019-00789
`Patent 8,399,514 B2
`
`
`
`The Office received a request for Precedential Opinion Panel (POP) review
`of an issue raised in this case. See Ex. 3001. The request was referred to the POP
`panel referenced above.
`Upon consideration of the request, it is
`ORDERED that the request for POP review is denied; and
`FURTHER ORDERED that the original panel maintains authority over all
`matters, including considering the submitted rehearing request.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`2
`
`
`
`IPR2019-00789
`Patent 8,399,514 B2
`
`For PETITIONER:
`
`Brian Sodikoff
`Brian.sodikoff@kattenlaw.com
`
`Christopher Ferenc
`Christopher.ferenc@kattenlaw.com
`
`Martin S. Masar III
`martin.masar@katten.com
`
`
`For PATENT OWNER:
`
`Barbara McCurdy
`Barbara.mccurdy@finnegan.com
`
`Mark Feldstein
`Mark.feldstein@finnegan.com
`
`Erin Sommers
`Erin.sommers@finnegan.com
`
`Pier DeRoo
`Pier.deroo@finnegan.com
`
`
`
`
`
`3
`
`